ARSA Gene Metachromatic Leukodystrophy Genetic Test in UAE | 2800 AED | DNA Labs UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS, validated against curated variant databases.
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Complimentary telephonic post-test clinical guidance with a DHA-licensed physician for result interpretation.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The ARSA NGS test screens the entire coding region of the arylsulfatase A gene for pathogenic variants linked to metachromatic leukodystrophy (MLD), a rare autosomal recessive lysosomal storage disorder. Comprehensive gene analysis provides definitive molecular evidence to support clinical diagnosis, carrier detection, and family planning decisions.

Feature	Our NGS Test (DNA Labs UAE)	Closest Alternative (Single-Gene Sanger)
Precision	Full gene sequencing and copy number analysis; greater than 99.9% sensitivity for point mutations and indels	Targeted exon-by-exon; may miss deep intronic or large deletions and duplications
Methodology	NGS with Illumina platform, bioinformatics pipeline aligned to GRCh38 genomic standards	Conventional Sanger sequencing
Turnaround	3–4 weeks, with expedited option on medical urgency	6–8 weeks

Physician Insight & Safety Protocols

“The ARSA genetic test provides deep molecular insight, yet results must always be interpreted alongside clinical presentation, biochemical markers, and family history. I strongly recommend pre-test genetic counseling to prepare families for the implications of positive, negative, or uncertain findings. A positive result does not automatically predict a severe phenotype; correlation with arylsulfatase A enzyme activity and neuroimaging is essential for accurate prognosis.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Advisory

Do not discontinue any prescribed medication or therapy without consulting your treating physician. Genetic results are informational and must not be used as the sole basis to alter treatment plans. Always maintain current care protocols until explicitly directed otherwise by your healthcare provider.

Exclusion Criteria & Emergency Red Flags

Patients who are unable or unwilling to provide informed consent or a valid clinical history.
Individuals under 18 years without legal guardian consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Emergency signs needing immediate care: acute neurological deterioration, loss of consciousness, new-onset seizures, or severe respiratory distress. Do not delay emergency care for this test.

Patient FAQ & Clinical Guidance

1. How accurate is this ARSA NGS test for diagnosing metachromatic leukodystrophy?

This test delivers 99.9% diagnostic sensitivity for ARSA gene mutations when complemented by enzyme analysis and clinical assessment. NGS covers all coding exons, splice sites, and known copy number variations associated with MLD. A negative result does not completely exclude the disease if biochemical findings are abnormal; further investigation may be needed. Every result is reviewed by a DHA-licensed physician and genetic counselor.

2. What sample types can be used, and is home collection available in the UAE?

We accept whole blood, extracted DNA, or a simple dried blood spot on an FTA card, all collected at your convenience. Our VIP mobile phlebotomy and temperature-controlled cold-chain home collection service operates daily from 8 AM to 11 PM, ensuring sample integrity throughout transit. FTA cards are ideal for paediatric patients or remote locations. Detailed pre-instructions and a genetic counseling session are provided prior to sampling.

3. Does the test require fasting or medication changes? What about genetic counseling?

No fasting or medication adjustments are needed for the ARSA gene test; continue all prescribed treatments as directed by your physician. A mandatory pre-test genetic counseling session is scheduled to construct a family pedigree, identify at-risk individuals, and discuss the scope of possible results. This consultation helps interpret the outcome and plan future care. Contact us via WhatsApp at +971 54 548 8731 to book your counseling appointment.

4. How will I receive my results, and what support is available afterward?

Results are delivered electronically through a secure patient portal within 3–4 weeks. A DHA-licensed physician provides a complimentary telephonic consultation to explain the findings, discuss clinical implications, and recommend next steps. Family members at risk may also be offered cascade testing and counseling upon request.

UAE Regulatory & Data Privacy Adherence

Data Protection Framework: All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data minimization, and secure storage protocols are strictly enforced.

Clinical Safety & Consent: Informed consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring every patient or guardian understands the scope, limitations, and implications of genetic testing before sample collection.

Certification: ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139. All laboratory processes adhere to international quality management standards.

Clinical & Logistical Metadata

Test Name	ARSA Gene Metachromatic Leukodystrophy Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)
Methodology Used	Next-Generation Sequencing (NGS) – Illumina Platform
ICD-10-CM Code	E75.23
LOINC Code	95362-9
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE